Celastrol suppresses growth and induces apoptosis of human hepatocellular carcinoma through the modulation of STAT3/JAK2 signaling cascade In Vitro and In Vivo

Cumulative evidences(s) have established that the constitutive activation of STAT3 plays a pivotal role in the proliferation, survival, metastasis, and angiogenesis and thus can contribute directly to the pathogenesis of hepatocellular carcinoma (HCC). Thus, novel agents that can inhibit STAT3 activ...

Full description

Bibliographic Details
Main Authors: Rajendran, P., Li, F., Shanmugam, M., Kannaiyan, R., Goh, J., Wong, K., Wang, W., Khin, E., Tergaonkar, V., Kumar, Alan Prem, Luk, J., Sethi, G.
Format: Journal Article
Published: American Association for Cancer Research 2012
Online Access:http://hdl.handle.net/20.500.11937/49936
_version_ 1848758354341527552
author Rajendran, P.
Li, F.
Shanmugam, M.
Kannaiyan, R.
Goh, J.
Wong, K.
Wang, W.
Khin, E.
Tergaonkar, V.
Kumar, Alan Prem
Luk, J.
Sethi, G.
author_facet Rajendran, P.
Li, F.
Shanmugam, M.
Kannaiyan, R.
Goh, J.
Wong, K.
Wang, W.
Khin, E.
Tergaonkar, V.
Kumar, Alan Prem
Luk, J.
Sethi, G.
author_sort Rajendran, P.
building Curtin Institutional Repository
collection Online Access
description Cumulative evidences(s) have established that the constitutive activation of STAT3 plays a pivotal role in the proliferation, survival, metastasis, and angiogenesis and thus can contribute directly to the pathogenesis of hepatocellular carcinoma (HCC). Thus, novel agents that can inhibit STAT3 activation have potential for both prevention and treatment of HCCs. The effect of celastrol on STAT3 activation, associated protein kinases, STAT3-regulated gene products, cellular proliferation, and apoptosis was investigated. The in vivo effect of celastrol on the growth of human HCC xenograft tumors in athymic nu/nu mice was also examined. We observed that celastrol inhibited both constitutive and inducible STAT3 activation, and the suppression was mediated through the inhibition of activation of upstream kinases c-Src, as well as Janus-activated kinase-1 and -2. Vanadate treatment reversed the celastrol-induced modulation of STAT3, suggesting the involvement of a tyrosine phosphatase. The inhibition of STAT3 activation by celastrol led to the suppression of various gene products involved in proliferation, survival, and angiogenesis. Celastrol also inhibited the proliferation and induced apoptosis in HCC cells. Finally, when administered intraperitoneally, celastrol inhibited STAT3 activation in tumor tissues and the growth of human HCC xenograft tumors in athymic nu/nu mice without any side effects. Overall, our results suggest for the first time that celastrol exerts its antiproliferative and proapoptotic effects through suppression of STAT3 signaling in HCC both in vitro and in vivo.
first_indexed 2025-11-14T09:42:39Z
format Journal Article
id curtin-20.500.11937-49936
institution Curtin University Malaysia
institution_category Local University
last_indexed 2025-11-14T09:42:39Z
publishDate 2012
publisher American Association for Cancer Research
recordtype eprints
repository_type Digital Repository
spelling curtin-20.500.11937-499362017-09-13T15:49:25Z Celastrol suppresses growth and induces apoptosis of human hepatocellular carcinoma through the modulation of STAT3/JAK2 signaling cascade In Vitro and In Vivo Rajendran, P. Li, F. Shanmugam, M. Kannaiyan, R. Goh, J. Wong, K. Wang, W. Khin, E. Tergaonkar, V. Kumar, Alan Prem Luk, J. Sethi, G. Cumulative evidences(s) have established that the constitutive activation of STAT3 plays a pivotal role in the proliferation, survival, metastasis, and angiogenesis and thus can contribute directly to the pathogenesis of hepatocellular carcinoma (HCC). Thus, novel agents that can inhibit STAT3 activation have potential for both prevention and treatment of HCCs. The effect of celastrol on STAT3 activation, associated protein kinases, STAT3-regulated gene products, cellular proliferation, and apoptosis was investigated. The in vivo effect of celastrol on the growth of human HCC xenograft tumors in athymic nu/nu mice was also examined. We observed that celastrol inhibited both constitutive and inducible STAT3 activation, and the suppression was mediated through the inhibition of activation of upstream kinases c-Src, as well as Janus-activated kinase-1 and -2. Vanadate treatment reversed the celastrol-induced modulation of STAT3, suggesting the involvement of a tyrosine phosphatase. The inhibition of STAT3 activation by celastrol led to the suppression of various gene products involved in proliferation, survival, and angiogenesis. Celastrol also inhibited the proliferation and induced apoptosis in HCC cells. Finally, when administered intraperitoneally, celastrol inhibited STAT3 activation in tumor tissues and the growth of human HCC xenograft tumors in athymic nu/nu mice without any side effects. Overall, our results suggest for the first time that celastrol exerts its antiproliferative and proapoptotic effects through suppression of STAT3 signaling in HCC both in vitro and in vivo. 2012 Journal Article http://hdl.handle.net/20.500.11937/49936 10.1158/1940-6207.CAPR-11-0420 American Association for Cancer Research unknown
spellingShingle Rajendran, P.
Li, F.
Shanmugam, M.
Kannaiyan, R.
Goh, J.
Wong, K.
Wang, W.
Khin, E.
Tergaonkar, V.
Kumar, Alan Prem
Luk, J.
Sethi, G.
Celastrol suppresses growth and induces apoptosis of human hepatocellular carcinoma through the modulation of STAT3/JAK2 signaling cascade In Vitro and In Vivo
title Celastrol suppresses growth and induces apoptosis of human hepatocellular carcinoma through the modulation of STAT3/JAK2 signaling cascade In Vitro and In Vivo
title_full Celastrol suppresses growth and induces apoptosis of human hepatocellular carcinoma through the modulation of STAT3/JAK2 signaling cascade In Vitro and In Vivo
title_fullStr Celastrol suppresses growth and induces apoptosis of human hepatocellular carcinoma through the modulation of STAT3/JAK2 signaling cascade In Vitro and In Vivo
title_full_unstemmed Celastrol suppresses growth and induces apoptosis of human hepatocellular carcinoma through the modulation of STAT3/JAK2 signaling cascade In Vitro and In Vivo
title_short Celastrol suppresses growth and induces apoptosis of human hepatocellular carcinoma through the modulation of STAT3/JAK2 signaling cascade In Vitro and In Vivo
title_sort celastrol suppresses growth and induces apoptosis of human hepatocellular carcinoma through the modulation of stat3/jak2 signaling cascade in vitro and in vivo
url http://hdl.handle.net/20.500.11937/49936